Rocket Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -2,339 | -2,254 | ||
EBITDA | -57,493 | -63,859 | -66,836 | -59,329 |
EBIT | -59,854 | -66,248 | -69,175 | -61,583 |
Net Income | -60,327 | -66,719 | -69,646 | -62,054 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -47,251 | -53,691 | -55,782 | -58,918 |
Cash | 163,635 | 65,599 | 38,607 | 35,276 |
Basic Shares | 97,530 | 94,158 | 93,746 | 93,549 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -7,098 | -6,266 | -5,373 | |
EBITDA | -273,205 | -236,622 | -213,688 | -161,719 |
EBIT | -243,720 | -219,954 | -167,092 | |
Net Income | -258,746 | -245,595 | -219,383 | -169,585 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -64,629 | |||
Free Cash Flow | -209,724 | -211,388 | -186,761 | -128,878 |
Cash | 163,635 | 55,904 | 140,517 | 232,694 |
Basic Shares | 94,807 | 84,009 | 68,148 | 63,235 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.62 |
2024-09-30 | -$0.71 |
2024-06-30 | -$0.74 |
2024-03-31 | -$0.66 |
